SCHEMBL8805

SCHEMBL8805

[CH]1CCCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15269897 1.00 CXCR4 (0.33)
Hydrochloric Acid SCHEMBL15732414 0.97
SCHEMBL157167 0.90
SCHEMBL420289 0.88
SCHEMBL1699103 0.88
SCHEMBL13739220 0.85
SCHEMBL193790 0.79
SCHEMBL9205 0.79
SCHEMBL519118 0.79
Hydrochloric Acid SCHEMBL29240889 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 28390 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217968-A1 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2024-07-04 US claimed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 WO claimed
WO-2024131265-A1 COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF 中国科学院合肥物质科学研究院 2024-06-27 WO claimed
WO-2024137358-A1 KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE IMAGO BIOSCIENCES, INC. (US) 2024-06-27 WO claimed
CN-118239953-A Compounds for the treatment of PI3K gamma mediated diseases and uses thereof 中国科学院合肥物质科学研究院 2024-06-25 CN claimed
EP-4380562-A1 PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION The Rockefeller University (US) 2024-06-12 EP claimed
EP-3849664-B1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2024-06-12 EP claimed
WO-2024115465-A1 PHARMACEUTICAL COMPOUNDS AS PARP7 AND/OR PARP1 INHIBITORS Duke Street Bio Limited (GB) 2024-06-06 WO claimed
US-20240158398-A1 INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE BLUEPRINT MEDICINES CORPORATION 2024-05-16 US claimed
CN-118019736-A Molecular gel compound designed based on cereblon protein and application thereof 标新生物医药科技(上海)有限公司 2024-05-10 CN claimed
US-4506099-A Process for producing substituted 1,11-diaminoundecanes CIBA-GEIGY CORPORATION (US) 1985-03-19 US claimed
EP-0133097-A1 Synergistin derivatives, their preparation and pharmaceutical compositions thereof RHONE-POULENC SANTE (FR) 1985-02-13 EP claimed
EP-0131374-A1 Process and intermediates for the preparation of penem derivatives PFIZER INC. (US) 1985-01-16 EP claimed
EP-0127543-A2 Antibiotic cephalosporin derivatives, process for their preparation and pharamceutical compositions containing them SANOFI (FR) 1984-12-05 EP claimed
US-4454158-A Allyl amine MAO inhibitors MERRELL TORAUDE ET COMPAGNIE (FR) 1984-06-12 US claimed
EP-0077298-A2 Process for making substituted 1,11-diaminoundecanes CIBA-GEIGY AG (CH) 1983-04-20 EP claimed
EP-0072710-A1 Carbapenem derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1983-02-23 EP claimed
EP-0067105-A2 Allyl amine MAO inhibitors MERRELL DOW FRANCE ET CIE (FR) 1982-12-15 EP claimed
US-4200628-A ANTIBIOTICS, BACTERICIDES SHIONOGI & CO., LTD. (JP) 1980-04-29 US claimed
EP-0001643-A2 Aminoglycoside derivatives, process for their manufacture, pharmaceutical compositions and carboxylic acids SHIONOGI & CO., LTD. (JP) 1979-05-02 EP claimed